A Study of Pioglitazone and Carboplatin in Patients With Advanced Solid Tumors
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Centre Francois Baclesse
BeiGene
Genentech, Inc.
G1 Therapeutics, Inc.
Icahn School of Medicine at Mount Sinai
National Cancer Institute (NCI)
Canadian Cancer Trials Group
Nektar Therapeutics
H. Lee Moffitt Cancer Center and Research Institute
iOMEDICO AG
AbbVie
AbbVie
Novartis
Mereo BioPharma
AstraZeneca
UNC Lineberger Comprehensive Cancer Center
Gustave Roussy, Cancer Campus, Grand Paris
AbbVie
National Institutes of Health Clinical Center (CC)
Eli Lilly and Company
M.D. Anderson Cancer Center
AstraZeneca
H. Lee Moffitt Cancer Center and Research Institute
US Oncology Research
Oncolytics Biotech
Pierre Fabre Medicament
M.D. Anderson Cancer Center
AbbVie
Oncolytics Biotech
Oncolytics Biotech
NYU Langone Health
Sanofi
City of Hope Medical Center
Amgen
Ludwig-Maximilians - University of Munich
Eli Lilly and Company